Production (Stage)
Aethlon Medical, Inc.
AEMD
$1.18
-$0.045-3.67%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.00M | 1.81M | 2.90M | 2.62M | 3.36M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.00M | 1.81M | 2.90M | 2.62M | 3.36M |
| Operating Income | -2.00M | -1.81M | -2.90M | -2.62M | -3.36M |
| Income Before Tax | -6.25M | -1.75M | -2.81M | -2.57M | -2.43M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.25M | -1.75M | -2.81M | -2.57M | -2.43M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.25M | -1.75M | -2.81M | -2.57M | -2.43M |
| EBIT | -2.00M | -1.81M | -2.90M | -2.62M | -3.36M |
| EBITDA | -1.92M | -1.73M | -2.82M | -2.53M | -3.27M |
| EPS Basic | -3.44 | -1.01 | -1.61 | -2.76 | -7.41 |
| Normalized Basic EPS | -2.15 | -0.63 | -1.01 | -1.72 | -6.30 |
| EPS Diluted | -3.44 | -1.01 | -1.61 | -2.76 | -7.41 |
| Normalized Diluted EPS | -2.15 | -0.63 | -1.01 | -1.72 | -6.30 |
| Average Basic Shares Outstanding | 1.82M | 1.75M | 1.74M | 932.20K | 327.40K |
| Average Diluted Shares Outstanding | 1.82M | 1.75M | 1.74M | 932.20K | 327.40K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |